Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Germantown, TN
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Nashville, TN
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Houston, TX
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Humble, TX
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Humble, TX
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Kingwood, TX
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Kingwood, TX
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
mi
from
Wahroonga,
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
mi
from
Wahroonga,
Click here to add this to my saved trials
Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants
Phase II Study of Late- Versus Early Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants.
Status: Enrolling
Updated:  11/1/2017
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants
Phase II Study of Late- Versus Early Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants.
Status: Enrolling
Updated: 11/1/2017
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors From Different Ethnic Groups
Status: Enrolling
Updated:  11/1/2017
Pima, Cochise, Santa Cruz Counties
mi
from
Tucson, AZ
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors From Different Ethnic Groups
Status: Enrolling
Updated: 11/1/2017
Pima, Cochise, Santa Cruz Counties
mi
from
Tucson, AZ
Click here to add this to my saved trials
MRI for Non-invasive Evaluation of Brain Stress
MRI for Non-invasive Evaluation of Brain Stress
Status: Enrolling
Updated:  11/1/2017
St. Louis Children's Hospital
mi
from
Saint Louis, MO
MRI for Non-invasive Evaluation of Brain Stress
MRI for Non-invasive Evaluation of Brain Stress
Status: Enrolling
Updated: 11/1/2017
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Electric Stimulation of the Eye to Improve Vision After Trauma
Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma
Status: Enrolling
Updated:  11/1/2017
Wills Eye Hospital
mi
from
Philadelphia, PA
Electric Stimulation of the Eye to Improve Vision After Trauma
Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma
Status: Enrolling
Updated: 11/1/2017
Wills Eye Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Electrical Stimulation for Recovery of Ankle Dorsiflexion in Chronic Stroke Survivors
Contralaterally Controlled NMES in Chronic Ankle Dorsiflexor Paresis After Stroke
Status: Enrolling
Updated:  11/2/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Electrical Stimulation for Recovery of Ankle Dorsiflexion in Chronic Stroke Survivors
Contralaterally Controlled NMES in Chronic Ankle Dorsiflexor Paresis After Stroke
Status: Enrolling
Updated: 11/2/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  11/2/2017
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 11/2/2017
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  11/2/2017
City of Hope
mi
from
Duarte, CA
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 11/2/2017
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Neuromuscular Ultrasound for Focal Neuropathies
Neuromuscular Ultrasound for Focal Neuropathies
Status: Enrolling
Updated:  11/2/2017
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Neuromuscular Ultrasound for Focal Neuropathies
Neuromuscular Ultrasound for Focal Neuropathies
Status: Enrolling
Updated: 11/2/2017
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Brain Dynamics in Different Stages of Arousal and Anesthesia
Brain Dynamics in Different Stages of Arousal and Anesthesia
Status: Enrolling
Updated:  11/2/2017
New York Presbyterian Hospital-Weill Cornell Medical College
mi
from
New York, NY
Brain Dynamics in Different Stages of Arousal and Anesthesia
Brain Dynamics in Different Stages of Arousal and Anesthesia
Status: Enrolling
Updated: 11/2/2017
New York Presbyterian Hospital-Weill Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  11/2/2017
Massachusetts General Hospital
mi
from
Boston, MA
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 11/2/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  11/2/2017
Univ of Massachusetts Med School
mi
from
Worcester, MA
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 11/2/2017
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  11/2/2017
Emory University
mi
from
Atlanta, GA
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 11/2/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Status: Enrolling
Updated:  11/2/2017
University of Colorado
mi
from
Boulder, CO
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Status: Enrolling
Updated: 11/2/2017
University of Colorado
mi
from
Boulder, CO
Click here to add this to my saved trials
Depression and Health Outcomes in Refractory Epilepsy
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated:  11/2/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Depression and Health Outcomes in Refractory Epilepsy
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated: 11/2/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Depression and Health Outcomes in Refractory Epilepsy
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated:  11/2/2017
Columbia University Medical Center
mi
from
New York, NY
Depression and Health Outcomes in Refractory Epilepsy
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated: 11/2/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
Women's Health Initiative Memory Study of Younger Women
Status: Enrolling
Updated:  11/2/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
Women's Health Initiative Memory Study of Younger Women
Status: Enrolling
Updated: 11/2/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Concussion and Post Traumatic Stress in Traumatic Brain Injury
Prospective Study of Concussion and PTSD in Structurally Brain Injured, Non-Structurally Brain Injured and Non-Brain Injured Trauma Victims in Bellevue HHC
Status: Enrolling
Updated:  11/3/2017
Bellevue HHC
mi
from
New York, NY
Concussion and Post Traumatic Stress in Traumatic Brain Injury
Prospective Study of Concussion and PTSD in Structurally Brain Injured, Non-Structurally Brain Injured and Non-Brain Injured Trauma Victims in Bellevue HHC
Status: Enrolling
Updated: 11/3/2017
Bellevue HHC
mi
from
New York, NY
Click here to add this to my saved trials
Electroencephalogram and Attention Deficit Hyperactivity Disorder Study
EEG and ADHD Study
Status: Enrolling
Updated:  11/3/2017
Rachel Upjohn Building
mi
from
Ann Arbor, MI
Electroencephalogram and Attention Deficit Hyperactivity Disorder Study
EEG and ADHD Study
Status: Enrolling
Updated: 11/3/2017
Rachel Upjohn Building
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Jordan Research & Education Institute: Sutter Alta Bates Summit
mi
from
Berkeley, CA
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Jordan Research & Education Institute: Sutter Alta Bates Summit
mi
from
Berkeley, CA
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
University of Southern California
mi
from
Los Angeles, CA
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
University of California-Davis
mi
from
Sacramento, CA
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
University of Michigan Health System -Multiple Sclerosis Center
mi
from
Ann Arbor, MI
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
University of Michigan Health System -Multiple Sclerosis Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
South Shore Neurologic Associates - Multiple Sclerosis Care Center
mi
from
Patchogue, NY
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
South Shore Neurologic Associates - Multiple Sclerosis Care Center
mi
from
Patchogue, NY
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Carolinas Medical Center (CMC)
mi
from
Charlotte, NC
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Carolinas Medical Center (CMC)
mi
from
Charlotte, NC
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Cleveland Clinic: Mellen Center for Multiple Sclerosis
mi
from
Cleveland, OH
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Cleveland Clinic: Mellen Center for Multiple Sclerosis
mi
from
Cleveland, OH
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Providence Multiple Sclerosis Center
mi
from
Portland, OR
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Providence Multiple Sclerosis Center
mi
from
Portland, OR
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Swedish Neuroscience Institute
mi
from
Seattle, WA
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Swedish Neuroscience Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
University of Colorado
mi
from
Aurora, CO
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated:  11/3/2017
Henry Ford Health System
mi
from
Detroit, MI
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Status: Enrolling
Updated: 11/3/2017
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
The Research Center of Southern California (Assessment)
mi
from
Carlsbad, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
The Research Center of Southern California (Assessment)
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Neuro-Pain Medical Center (Assessment)
mi
from
Fresno, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Neuro-Pain Medical Center (Assessment)
mi
from
Fresno, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Westview Clinical Research (Assessment)
mi
from
Placentia, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Westview Clinical Research (Assessment)
mi
from
Placentia, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
NeuroMedical Research Institute (Assessment)
mi
from
Panama City, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
NeuroMedical Research Institute (Assessment)
mi
from
Panama City, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Medsol Clinical Research Center (Assessment)
mi
from
Port Charlotte, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Medsol Clinical Research Center (Assessment)
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Neurostudies, Inc. (Assessment)
mi
from
Port Charlotte, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Neurostudies, Inc. (Assessment)
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of South Florida (Assessment)
mi
from
Tampa, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of South Florida (Assessment)
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
OSF Saint Francis Healthcare System (Assessment)
mi
from
Peoria, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
OSF Saint Francis Healthcare System (Assessment)
mi
from
Peoria, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Indiana Medical Research, Elkhart Clinic (Assessment)
mi
from
Elkhart, IN
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Indiana Medical Research, Elkhart Clinic (Assessment)
mi
from
Elkhart, IN
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Kansas Institute of Research (Assessment)
mi
from
Overland Park, KA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Kansas Institute of Research (Assessment)
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
NeuroMedical Clinic of Central Louisiana (Assessment)
mi
from
Alexandria, LA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
NeuroMedical Clinic of Central Louisiana (Assessment)
mi
from
Alexandria, LA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Neurology and Neuroscience Associates, Inc. (Assessment)
mi
from
Akron, OH
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Neurology and Neuroscience Associates, Inc. (Assessment)
mi
from
Akron, OH
Click here to add this to my saved trials